Friday, October 24, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

AMD Shares Face Volatility as AI Strategy Comes Under Scrutiny

Felix Baarz by Felix Baarz
September 7, 2025
in AI & Quantum Computing, Analysis, Semiconductors, Tech & Software
0
AMD Stock
0
SHARES
133
VIEWS
Share on FacebookShare on Twitter

Advanced Micro Devices (AMD) finds itself at a critical juncture as confidence in its artificial intelligence growth strategy shows signs of wavering. The semiconductor manufacturer’s ambitious plans for its new MI350 graphics processor have encountered skepticism following a significant analyst downgrade, raising fundamental questions about whether the company can achieve its AI breakthrough objectives or face substantial setbacks.

Mixed Analyst Sentiment Creates Uncertainty

The investment community appears deeply divided on AMD’s near-term prospects. Seaport Global Securities triggered the latest wave of concern by downgrading AMD shares from “Buy” to “Neutral,” citing disappointing progress in the AI accelerator business. According to their assessment, supply chain reports suggest AMD is struggling to convert initial customer interest from its summer AI event into substantial volume orders, potentially extending the timeline for gaining meaningful market share.

This cautious stance contrasts sharply with maintained optimism from other major institutions. Bank of America continues to recommend AMD as a “Buy” with a $200 price target, while Citi recently reaffirmed its “Hold” position with a $180 target. These conflicting perspectives present investors with a complex decision-making environment and reflect the significant division on Wall Street regarding AMD’s immediate future.

Should investors sell immediately? Or is it worth buying AMD?

Geopolitical Headwinds Impact Financial Performance

Beyond analyst disagreements, AMD continues to navigate challenging geopolitical conditions that directly affect its financial results. Ongoing U.S. export restrictions on advanced AI chips to China have created substantial headwinds, with the company already projecting approximately $1.5 billion in lost revenue for 2025 due to these regulations. The impact has been particularly severe, resulting in a significant $800 million write-down of unsalable MI308 GPUs that has directly pressured profitability metrics.

MI350 Series Offers Growth Potential

Despite these challenges, AMD’s internal projections present a more optimistic outlook. The company anticipates third-quarter 2025 revenue of approximately $8.7 billion, representing impressive year-over-year growth of about 28 percent. Central to this positive forecast is the aggressive scaling of the new AMD Instinct MI350 series, which management identifies as crucial for driving expansion within the data center segment.

AMD shares recently traded at €128.58, having declined a notable 7.4 percent during Friday’s session. The essential question for investors remains whether the MI350 series can deliver the anticipated market breakthrough or whether recent skepticism about AMD’s AI capabilities will prove justified.

Ad

AMD Stock: Buy or Sell?! New AMD Analysis from October 24 delivers the answer:

The latest AMD figures speak for themselves: Urgent action needed for AMD investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 24.

AMD: Buy or sell? Read more here...

Tags: AMD
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Cellectar Biosciences Stock
Analysis

Cellectar Biosciences at a Critical Juncture: Regulatory and Financial Developments Converge

October 24, 2025
Super Micro Computer Stock
AI & Quantum Computing

Super Micro Stock Plummets After Stunning Forecast Downgrade

October 24, 2025
Oxford Square Capital Stock
Analysis

High-Yield Gamble: The Oxford Square Capital Investment Dilemma

October 24, 2025
Next Post
Edwards Lifesciences Stock

Edwards Lifesciences: A Study in Market Contradictions

Palantir Stock

Palantir Leadership Offloads Shares: A Signal to Investors?

Universal Health Realty Income Stock

Healthcare REIT Gains Momentum Amid Sector Challenges

Recommended

Crown Castle Stock

Crown Castle Navigates Major Restructuring Under New Leadership

1 month ago
Micron Stock

Memory Chip Demand Surges as AI Revolution Intensifies

3 weeks ago
AeroVironment Stock

AeroVironment’s Growth Trajectory: Impressive Revenue Gains Mask Margin Pressures

1 month ago
Biotechnology Trading online

Analysts Downgrade Immuneering Corporation Due to Concerns Over Efficacy of IMM1104

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Nike NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

High-Yield Gamble: The Oxford Square Capital Investment Dilemma

Freddie Mac Investors Face Critical Juncture Amid Conflicting Forces

Riot Blockchain’s Strategic Pivot to AI Computing Captivates Market

Can Polestar Navigate Its Deepening Financial Crisis?

Strong T-Mobile Results Met With Unexpected Market Skepticism

Oppenheimer Holdings Faces Critical Test with Q3 Earnings Release

Trending

Cellectar Biosciences Stock
Analysis

Cellectar Biosciences at a Critical Juncture: Regulatory and Financial Developments Converge

by Felix Baarz
October 24, 2025
0

Cellectar Biosciences finds itself at a pivotal moment, with a convergence of regulatory progress, financial maneuvers, and...

Super Micro Computer Stock

Super Micro Stock Plummets After Stunning Forecast Downgrade

October 24, 2025
3M Stock

3M Shares Surge on Strong Quarterly Performance and Upbeat Forecast

October 24, 2025
Oxford Square Capital Stock

High-Yield Gamble: The Oxford Square Capital Investment Dilemma

October 24, 2025
Federal Home Loan Mortgage Stock

Freddie Mac Investors Face Critical Juncture Amid Conflicting Forces

October 24, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Cellectar Biosciences at a Critical Juncture: Regulatory and Financial Developments Converge
  • Super Micro Stock Plummets After Stunning Forecast Downgrade
  • 3M Shares Surge on Strong Quarterly Performance and Upbeat Forecast

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com